topiramate

(redirected from Trokendi XR)
Also found in: Medical.
Translations

topiramate

n topiramato
References in periodicals archive ?
Cadila, alongside subsidiary Zydus Pharmaceuticals Inc, stated in a BSE filing that it had reached an agreement with Maryland-based Supernus Pharmaceuticals to resolve all outstanding patent litigation in relation to Trokendi XR (topiramate).
M2 EQUITYBITES-February 9, 2017-Supernus awarded eighth US patent for antiepileptic drug Trokendi XR
M2 PHARMA-February 9, 2017-Supernus awarded eighth US patent for antiepileptic drug Trokendi XR
M2 EQUITYBITES-January 31, 2017-Supernus expands protection coverage for Trokendi XR via seventh US patent
M2 PHARMA-January 31, 2017-Supernus expands protection coverage for Trokendi XR via seventh US patent
M2 EQUITYBITES-August 23, 2016-Supernus Pharmaceuticals receives tentative US FDA approval for Trokendi XR Supplemental New Drug Application
M2 PHARMA-August 23, 2016-Supernus Pharmaceuticals receives tentative US FDA approval for Trokendi XR Supplemental New Drug Application
M2 EQUITYBITES-August 22, 2016-Supernus passes US FDA tentative approval for expanded label of Trokendi XR to include migraine prophylaxis in adults
M2 PHARMA-August 22, 2016-Supernus passes US FDA tentative approval for expanded label of Trokendi XR to include migraine prophylaxis in adults
It has two marketed products for epilepsy, Oxtellar XR (extended-release oxcarbazepine) and Trokendi XR (extended-release topiramate).
M2 PHARMA-October 23, 2015-Supernus's NDA for Trokendi XR Label accepted for US FDA's review
M2 EQUITYBITES-October 23, 2015-Supernus's NDA for Trokendi XR Label accepted for US FDA's review